NBEO Treatment and Management of Ocular Disease (TMOD) Practice Test
Build your confidence for NBEO Treatment and Management of Ocular Disease (TMOD). Practice the concepts, understand the answers, and strengthen your knowledge one question at a time.
Try a sample questionExam overview and details
The NBEO Treatment and Management of Ocular Disease (TMOD) Practice Test is a critical preparatory resource for optometrists seeking board certification through the National Board of Examiners in Optometry (NBEO). This practice test is meticulously designed to mirror the rigor and scope of the official TMOD examination, which assesses a candidate's ability to diagnose, treat, and manage a wide spectrum of ocular and systemic conditions. Covering anterior segment disease, glaucoma pharmacotherapy, ocular pharmacology, posterior segment disease, and systemic disease management, this test ensures that practitioners are proficient in evidence-based clinical decision-making. Success on the TMOD exam is a hallmark of professional competence, demonstrating mastery in therapeutic pharmaceutical agents, disease progression monitoring, and interdisciplinary care coordination. For optometrists, achieving this certification validates advanced clinical skills, enhances patient safety, and fulfills licensure requirements in many jurisdictions. This practice test provides a realistic simulation of exam conditions, helping candidates identify knowledge gaps, refine test-taking strategies, and build confidence. By engaging with this content, practitioners position themselves as leaders in comprehensive eye care, capable of managing complex cases that intersect with systemic health. The TMOD certification is not merely a credential; it is a testament to a clinician's commitment to the highest standards of ocular disease management and lifelong learning.
Sample Questions
Choose an answer and explore the explanation to see how practice works.
A 55-year-old woman with asthma and newly diagnosed primary open-angle glaucoma has untreated intraocular pressures of 28 mm Hg OU and moderate cupping with corresponding field loss. She uses albuterol as needed. Which of the following is the most appropriate initial agent?
A 63-year-old woman with primary open-angle glaucoma has been well controlled on latanoprost for 6 years. Recent Humphrey visual fields show progression of a superior arcuate defect in the right eye despite intraocular pressures consistently in the low teens. She has excellent compliance and no medication side effects. Which of the following is the most appropriate next step?
A 68-year-old man with primary open-angle glaucoma controlled on latanoprost for 4 years develops increasing conjunctival hyperemia, periocular skin darkening, and lengthening of his eyelashes. He is bothered by the appearance. Intraocular pressure remains at target. Which of the following is the most appropriate next step?
A 66-year-old woman with exfoliative glaucoma and prior SLT has used bimatoprost and timolol for 4 years. IOP is 16 mmHg but she has new medication-related periorbitopathy with deepening superior sulcus and lash growth asymmetry. Which option best preserves IOP control while reversing cosmetic side effects?
A 29-year-old female daily disposable contact lens wearer presents with acute onset severe left eye pain, photophobia, and tearing that began 12 hours ago. Best corrected visual acuity is 20/20 OD and 20/50 OS. Slit-lamp examination reveals a classic dendritic epithelial lesion with terminal bulbs that stains brightly with fluorescein on the left cornea. No anterior chamber reaction or stromal infiltrate is present. Which of the following is the most appropriate initial treatment?
Exam insights and study advice
Passing the NBEO TMOD exam is a transformative milestone for optometrists, directly impacting career trajectory and professional credibility. This certification is often a prerequisite for therapeutic licensure, allowing practitioners to prescribe medications, manage glaucoma, and treat ocular emergencies independently. In a competitive healthcare landscape, TMOD certification distinguishes you as a specialist in medical eye care, opening doors to hospital-based practices, surgical co-management roles, and leadership positions in multidisciplinary clinics. Employers and peers recognize this credential as a gold standard for clinical excellence, often correlating with higher reimbursement rates, expanded scope of practice, and increased patient trust. Furthermore, the knowledge validated by this exam directly improves patient outcomes-from early detection of diabetic retinopathy to precise management of uveitis. By mastering the TMOD blueprint, you demonstrate not only academic rigor but also a practical, patient-centered approach to care. This certification is your professional passport to advanced practice, career mobility, and industry-wide recognition as a top-tier optometric clinician.